You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
一品紅(300723.SZ):子公司擬斥500萬美元參與Arthrosi公司C3輪優先股融資 持股升至18.68%
格隆匯 01-10 16:35

格隆匯1月10日丨一品紅(300723.SZ)公佈,公司於2023年1月10日召開了第三屆董事會第十四次會議和第三屆監事會第十次會議,審議通過了《關於與關聯方共同投資暨關聯交易的議案》,同意全資子公司瑞騰生物(香港)有限公司(英文名:Reichstein Biotech (HK) Co.Limited,簡稱“瑞騰生物(香港)”)以自有資金500萬美元(摺合人民幣約3485萬元)參與Arthrosi Therapeutics,Inc.(簡稱:“Arthrosi”)的C3輪優先股融資。

增資完成後,瑞騰生物(香港)將獲得Arthrosi新發股份69.4637萬股。同時,公司關聯方Montesy Capital Holding Ltd將出資1000萬美元認購138.9274萬股。投資完成後,預計子公司瑞騰生物(香港)持有Arthrosi的股份將從17.78%上升至18.68%。

公司表示,該次與關聯方共同投資暨關聯交易的事項,符合公司業務發展及戰略規劃需要,有利於提升公司的研發能力和管線產品儲備,符合公司業務發展規劃佈局和長期發展戰略。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account